The global Inhalable Drug Delivery Devices (IDDD) market is projected to expand at a moderate rate during the forecast period. Factors such as increasing prevalence and incidence of asthmatic cases, chronic and acute diseases are expected to drive the global Inhalable Drug Delivery Devices (IDDD) market during the forecast period. According to World Health Organization (WHO), around 300 million people globally are suffering from asthma.
Moreover, technological advancements in inhalable drugs delivery systems such as nebulizers, dry powder inhalers, pressurized metered-dose inhalers are expected to boost the market growth. Moreover, large-scale efforts of government and non-governmental organizations for spreading awareness about the disease along with rising R&D activities to find a cure for asthma, chronic and acute diseases are the other important factors expected to boost the growth of the Inhalable Drug Delivery Devices (IDDD) market in near future. In addition to this, growing health care expenditure and increasing demand for advanced drugs are further driving the expansion of this market globally.
On the downside, a lack of awareness among patients and health care providers about the disease in developing countries along with the high cost of devices is likely to hamper the global Inhalable Drug Delivery Devices (IDDD) market during the forecast period.
Covid-19 Impact on Healthcare Biometrics Market:
In addition, the current Healthcare Biometrics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Healthcare Biometrics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Inhalable Drug Delivery Devices (IDDD) Market Segment Overview
Based on product type the market is segmented into pressurized metered-dose inhalers, nebulizers, dry powder inhalers, thermal vaporization aerosol devices, and others of which the dry powder inhalers segment holds the largest share of the market. This is because these products are highly effective to treat and show better results in comparison with other forms.
Based on End-user, the market is segmented into hospitals and clinics, ambulatory care centers, home care, and others, of which the hospitals and clinics segment is expected to grow at the highest rate in the coming years. The rising number of hospital admissions due to Chronic Obstructive Pulmonary Diseases (COPD) and asthma is also a major factor that’s driving the demand for Inhalable Drug Delivery Devices (IDDD)s.
Inhalable Drug Delivery Devices (IDDD) Market, By Product Type
· Pressurized metered-dose inhalers
· Nebulizers
· Dry powder inhalers
· Thermal vaporization aerosol devices
· Others.
Inhalable Drug Delivery Devices (IDDD) Market, By End-user
· Hospitals and clinics
· Ambulatory care center
· Homecare
· Others
Inhalable Drug Delivery Devices (IDDD) Market Regional Overview
Region-wise, North America dominated the global Inhalable Drug Delivery Devices (IDDD) market and is expected to continue its dominance during the forecast period. Factors such as advanced technology, rising awareness among people about the diagnosis of the disease, and high health care expenditure propel the growth of the market in North America. similarly, Europe is also expected to account for a significant share of the global market owing to well-established health care infrastructure. Additionally, both regions show a high market share for Inhalable Drug Delivery Devices (IDDD) owning to the various awareness programs conducted by governments, organizations, and companies to improve treatment options for COPD.
Inhalable Drug Delivery Devices (IDDD) Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Inhalable Drug Delivery Devices (IDDD) Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Inhalable Drug Delivery Devices (IDDD) are highlighted below.
· In April 2021, Cipla launched Niveoli-the first extra-fine particle inhaler developed in India. The inhaler comprises beclomethasone-formoterol and hydrofluoroalkane (HFA), which ensures targeted delivery to small airways in asthma and COPD patients.
Inhalable Drug Delivery Devices (IDDD) Market, Key Players
· Bespak
· Propeller Health
· Boehringer Ingelheim International GmbH
· OMRON Corporation
· GlaxoSmithKline plc
· AstraZeneca
· Sunovion Pharmaceuticals Inc.
· Pfizer Inc.
· F. Hoffmann-La Roche Ltd
· Monaghan Medical Corporation.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product Type
- 5.2.1. Pressurized metered-dose inhalers
- 5.2.2. Nebulizers
- 5.2.3. Dry powder inhalers
- 5.2.4. Thermal vaporization aerosol devices
- 5.2.5. Others.
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Hospitals and clinics
- 5.3.2. Ambulatory care center
- 5.3.3. Home care
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East, and Africa
6. North America Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product Type
- 6.2.1. Pressurized metered-dose inhalers
- 6.2.2. Nebulizers
- 6.2.3. Dry powder inhalers
- 6.2.4. Thermal vaporization aerosol devices
- 6.2.5. Others.
- 6.3. Market Analysis, Insights and Forecast – By End-user
- 6.3.1. Hospitals and clinics
- 6.3.2. Ambulatory care center
- 6.3.3. Home care
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product Type
- 7.2.1. Pressurized metered-dose inhalers
- 7.2.2. Nebulizers
- 7.2.3. Dry powder inhalers
- 7.2.4. Thermal vaporization aerosol devices
- 7.2.5. Others.
- 7.3. Market Analysis, Insights and Forecast – By End-user
- 7.3.1. Hospitals and clinics
- 7.3.2. Ambulatory care center
- 7.3.3. Home care
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product Type
- 8.2.1. Pressurized metered-dose inhalers
- 8.2.2. Nebulizers
- 8.2.3. Dry powder inhalers
- 8.2.4. Thermal vaporization aerosol devices
- 8.2.5. Others.
- 8.3. Market Analysis, Insights and Forecast – By End-user
- 8.3.1. Hospitals and clinics
- 8.3.2. Ambulatory care center
- 8.3.3. Home care
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product Type
- 9.2.1. Pressurized metered-dose inhalers
- 9.2.2. Nebulizers
- 9.2.3. Dry powder inhalers
- 9.2.4. Thermal vaporization aerosol devices
- 9.2.5. Others.
- 9.3. Market Analysis, Insights and Forecast – By End-user
- 9.3.1. Hospitals and clinics
- 9.3.2. Ambulatory care center
- 9.3.3. Home care
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Bespak
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Propeller Health
- 10.6. Boehringer Ingelheim International GmbH
- 10.7. OMRON Corporation
- 10.8. GlaxoSmithKline plc
- 10.9. AstraZeneca
- 10.10. Sunovion Pharmaceuticals Inc.
- 10.11. Pfizer Inc.
- 10.12. F. Hoffmann-La Roche Ltd
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
